Related Experiment Video
Updated: Sep 12, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Enhancer RNAs contribute to genome reprogramming driven by a GATA3 noncoding variant in leukaemia
Thayana da Conceição Barbosa1, Caroline Pires Poubel1,2, Ana Luiza Tardem Maciel1
1Genetics of Acute Leukaemia Laboratory (GenLAb), Research Centre, Instituto Nacional de Câncer (INCA), Rua André Cavalcanti, 37, 6th Floor, Rio de Janeiro, RJ, 20231-050, Brazil.
Abstract:
The GATA3 noncoding variant rs3824662 has been implicated in the pathogenesis of Ph-like B-ALL, where it is associated with extensive chromatin reorganisation, resulting in the dysregulation of multiple genes, including CRLF2 overexpression. Given the altered chromatin landscape and increased accessibility of GATA3 binding regions associated with the rs3824662 variant, we investigated the potential role of enhancer RNAs (eRNAs) located near the GATA3 locus in regulating CRLF2 expression. We found that the expression of eRNA_G3, located at chr10:8,443,562-8,449,563, was positively correlated with CRLF2 expression. Notably, eRNA_G3 was significantly upregulated in Ph-like ALL cases carrying the GATA3 rs3824662 variant. These findings suggest that both rs3824662 and eRNAs may cooperatively contribute to the regulatory mechanisms governing GATA3 and CRLF2 expression in Ph-like ALL.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
RNA Polymerase II Accessory Proteins
Lineage Commitment
Methods of Nuclear Reprogramming
General Transcription Factors
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

